All Stories

  1. Forecasting Upper Bounds for Daily New COVID-19 Infections Using Tolerance Limits
  2. Distribution of microRNA Counts Across Human Chromosomes
  3. Medical Benefits and Polymer Applications of Grapes
  4. EWMA Control Chart Integrated with Time Series Models for COVID-19 Surveillance
  5. A Review of Nanotechnology in microRNA Detection and Drug Delivery
  6. Advantages of animal leather over alternatives and its medical applications
  7. Anti-NMDA Receptor Encephalitis, Human Papillomavirus, and microRNA
  8. Beneficial medicinal effects and material applications of rose
  9. The Potential of Collagen Treatment for Comorbid Diseases
  10. Tolerance limits for mixture‐of‐normal distributions with application to COVID‐19 data
  11. Biomaterials in Medical Applications
  12. The Human Pre-miRNA Distance Distribution for Exploring Disease Association
  13. microRNA pathological mechanisms between Parkinson's disease, Alzheimer's disease, glaucoma and macular degeneration
  14. The distance distribution of human microRNAs in MirGeneDB database
  15. Phylogenetic Tree Selection by Testing Substitution Number in Clade
  16. Exploring the Causal Effect of Constipation on Parkinson’s Disease Through Mediation Analysis of Microbial Data
  17. A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson’s Disease
  18. COVID−19, Anti-NMDA Receptor Encephalitis and MicroRNA
  19. microRNA Biomarkers in Clinical Study
  20. Multiple imputation confidence intervals for the mean of the discrete distributions for incomplete data
  21. A Review of the Effects of Collagen Treatment in Clinical Studies
  22. The Association between Migraine and Depression based on miRNA Biomarkers and Cohort Studies
  23. MicroRNAs, Multiple Sclerosis, and Depression
  24. Editorial: miRNAs and Neurological Diseases
  25. MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
  26. Confidence intervals for the proportion of conformance
  27. Exploring the Association of Autism Spectrum Disorders and Constipation through Analysis of the Gut Microbiome
  28. Phylogenetic analysis of microRNA biomarkers for amyotrophic lateral sclerosis
  29. The Generalized Bayes Method for High-Dimensional Data Recognition with Applications to Audio Signal Recognition
  30. MicroRNA, Diabetes Mellitus and Colorectal Cancer
  31. The Association between Depression and Gastroesophageal Reflux based on Phylogenetic Analysis of miRNA Biomarkers
  32. <p>Exploring Diversity of COVID‑19 Based on Substitution Distance</p>
  33. Monitoring Change Points by a Sign Change Method
  34. MicroRNAs and Apoptosis in Colorectal Cancer
  35. Constructing exact tolerance intervals for the exponential distribution based on record values
  36. Anti-NMDA Receptor Encephalitis: Efficacy of Treatment for Male Patients and miRNA Biomarker
  37. Logistic Regression Method for Ligand Discovery
  38. Exact two‐sided tolerance interval controlling tail proportions for sample variances
  39. Anti-NMDA Receptor Encephalitis, Vaccination and Virus
  40. Vaccines and Neurological Disease
  41. Phylogenetic Analysis to Explore the Association Between Anti-NMDA Receptor Encephalitis and Tumors Based on microRNA Biomarkers
  42. Tolerance interval for the mixture normal distribution
  43. Exploring MicroRNA Biomarkers for Parkinson’s Disease from mRNA Expression Profiles
  44. How can we identify Amyotrophic Lateral Sclerosis with blood test?
  45. A protocol for investigating the association of vaccination and anti-NMDA receptor encephalitis
  46. Constructing Tolerance Intervals for the Number of Defectives Using Both High- and Low-Resolution Data
  47. Why ALS is often associated with cancers?
  48. A control chart for the lognormal standard deviation
  49. Anti-NMDA Receptor Encephalitis and Vaccination
  50. Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis
  51. On the monitoring of mixture simple linear profiles
  52. Efficacies of treatments for anti-NMDA receptor encephalitis
  53. Corrigendum to “Variance estimation for nucleotide substitution models” [Mol. Phylogenet. Evol. 90 (2015) 97–103]
  54. Multivariate control charts based on the James–Stein estimator
  55. Variance estimation for nucleotide substitution models
  56. Control Charts for the Lognormal Mean
  57. Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue
  58. Correction: Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  59. Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  60. Shrinkage regression-based methods for microarray missing value imputation
  61. RRSM with a data-dependent threshold for miRNA target prediction
  62. Bayesian Ranking Responses in Multiple-Response Questions
  63. Protein-specific Scoring Method for Ligand Discovery
  64. Confidence intervals for a bounded mean in exponential families
  65. Phylogenetic tree selection by the adjustedk-means approach
  66. Human microRNA target identification by RRSM
  67. Yeast cell cycle transcription factors identification by variable selection criteria
  68. Confidence intervals for the substitution number in the nucleotide substitution models
  69. Constructing Biological Pathways by a Two-Step Counting Approach
  70. Approximate Tolerance Limits Under Log-Location-Scale Regression Models in the Presence of Censoring
  71. Closed Form Prediction Intervals Applied for Disease Counts
  72. The monotone boundary property and the full coverage property of confidence intervals for a binomial proportion
  73. Comparison of control charts for low defective rate
  74. Increasing MicroRNA target prediction confidence by the relative R2 method
  75. Tolerance Intervals With Improved Coverage Probabilities for Binomial and Poisson Variables
  76. Improved variance estimators for one- and two-parameter models of nucleotide substitution
  77. Confidence intervals for the mean of a normal distribution with restricted parameter space
  78. Coverage probability of prediction intervals for discrete random variables
  79. Exact average coverage probabilities and confidence coefficients of confidence intervals for discrete distributions
  80. Exact confidence coefficients of simultaneous confidence intervals for multinomial proportions
  81. Ranking responses in multiple-choice questions
  82. ϵ-Admissible Estimators for Normal and Poisson Means
  83. Estimation of the Probability of Passing the USP Dissolution Test
  84. Modified p-values for one-sided testing in restricted parameter spaces
  85. Modified p-Value of Two-Sided Test for Normal Distribution with Restricted Parameter Space
  86. Improved confidence estimators for confidence sets of location parameters
  87. Improved estimation of accuracy in simple hypothesis versus simple alternative testing
  88. Improved confidence estimators for the usual one-sided confidence intervals for the ratio of two normal variances
  89. Admissibility of Confidence Estimators in the Regression Model
  90. The problem of low counts in a signal plus noise model
  91. Brown's paradox in the estimated confidence approach
  92. Estimated confidence under ancillary statistic everywhere-valid constraint
  93. Admissibility of the constant-coverage probability estimator for estimating the coverage function of certain confidence interval